INVO Bioscience Stock (NASDAQ: INVO) stock price, news, charts, stock research, profile.
Open | $1.030 |
Close | $1.060 |
Volume / Avg. | 315.570K / 3.767M |
Day Range | 1.030 - 1.098 |
52 Wk Range | 0.500 - 10.498 |
Market Cap | $2.825M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.44% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of INVO Bioscience (NASDAQ: INVO) through any online brokerage.
Other companies in INVO Bioscience’s space includes: Acutus Medical (NASDAQ:AFIB), Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX) and Venus Concept (NASDAQ:VERO).
The latest price target for INVO Bioscience (NASDAQ: INVO) was reported by Roth Capital on Wednesday, April 13, 2022. The analyst firm set a price target for 2.00 expecting INVO to rise to within 12 months (a possible 94.17% upside). 0 analyst firms have reported ratings in the last year.
The stock price for INVO Bioscience (NASDAQ: INVO) is $1.03 last updated April 29, 2024 at 6:35 PM EDT.
There are no upcoming dividends for INVO Bioscience.
INVO Bioscience’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for INVO Bioscience.
INVO Bioscience is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.